Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,758 | 1,069 | 97.6% |
| Gift | $262.89 | 1 | 1.4% |
| Education | $177.67 | 12 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,532 | 134 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,249 | 132 | $0 (2024) |
| Lilly USA, LLC | $2,142 | 135 | $0 (2024) |
| PFIZER INC. | $1,294 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,216 | 64 | $0 (2024) |
| Novo Nordisk Inc | $1,107 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $910.94 | 56 | $0 (2024) |
| Merck Sharp & Dohme LLC | $736.72 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $676.63 | 42 | $0 (2022) |
| Amgen Inc. | $676.36 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,104 | 164 | ABBVIE INC. ($736.18) |
| 2023 | $2,882 | 154 | ABBVIE INC. ($733.08) |
| 2022 | $1,707 | 101 | ABBVIE INC. ($394.96) |
| 2021 | $1,403 | 92 | Lilly USA, LLC ($217.50) |
| 2020 | $1,354 | 93 | Allergan, Inc. ($165.19) |
| 2019 | $2,188 | 141 | Lilly USA, LLC ($348.57) |
| 2018 | $2,535 | 162 | Lilly USA, LLC ($363.41) |
| 2017 | $3,024 | 175 | AstraZeneca Pharmaceuticals LP ($442.35) |
All Payment Transactions
1,082 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Greer Laboratories, Inc. | Palforzia (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Allergy Treatment | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Obesity | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.74 | General |
| 10/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 8,767 | 13,673 | $1.1M | $513,059 |
| 2022 | 54 | 8,659 | 13,201 | $1.1M | $482,732 |
| 2021 | 50 | 9,422 | 14,144 | $1.1M | $432,932 |
| 2020 | 50 | 8,191 | 11,825 | $927,190 | $343,663 |
All Medicare Procedures & Services
204 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 772 | 1,445 | $308,015 | $138,426 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 778 | 1,248 | $180,054 | $81,846 | 45.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 364 | 364 | $84,084 | $50,069 | 59.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 181 | 181 | $55,470 | $49,716 | 89.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 199 | 199 | $35,820 | $15,889 | 44.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 62 | 378 | $51,228 | $14,296 | 27.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 531 | 844 | $39,617 | $13,892 | 35.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 58 | 345 | $46,608 | $13,293 | 28.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 587 | 957 | $35,830 | $12,505 | 34.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 169 | 169 | $15,210 | $12,012 | 79.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 645 | 1,086 | $29,018 | $11,219 | 38.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 643 | 1,194 | $17,910 | $9,954 | 55.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 149 | 170 | $25,500 | $8,346 | 32.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 643 | 1,082 | $24,410 | $8,211 | 33.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 357 | 466 | $19,628 | $6,860 | 34.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 185 | 185 | $8,159 | $6,125 | 75.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 351 | 597 | $16,191 | $5,655 | 34.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 170 | 170 | $7,497 | $5,629 | 75.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 301 | 387 | $15,898 | $5,548 | 34.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $9,421 | $5,477 | 58.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $14,760 | $5,356 | 36.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 21 | $10,122 | $4,965 | 49.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 49 | 53 | $7,685 | $3,671 | 47.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 93 | 206 | $5,525 | $3,228 | 58.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 99 | 130 | $4,940 | $2,158 | 43.7% |
About Dr. Andrew Hirsch, DO
Dr. Andrew Hirsch, DO is a Family Medicine healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932147147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Hirsch, DO has received a total of $18,198 in payments from pharmaceutical and medical device companies, with $3,104 received in 2024. These payments were reported across 1,082 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($17,758).
As a Medicare-enrolled provider, Hirsch has provided services to 35,039 Medicare beneficiaries, totaling 52,843 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 204 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Goshen, NY
- Active Since 06/02/2006
- Last Updated 09/27/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932147147
Products in Payments
- FARXIGA (Drug) $1,719
- UBRELVY (Drug) $1,039
- TRULICITY (Drug) $961.59
- JARDIANCE (Drug) $739.01
- VRAYLAR (Drug) $589.08
- XARELTO (Drug) $515.31
- QULIPTA (Drug) $481.51
- Ozempic (Drug) $480.48
- XIFAXAN (Drug) $437.70
- ENTRESTO (Drug) $436.88
- JANUVIA (Drug) $414.53
- TRADJENTA (Drug) $406.64
- ELIQUIS (Drug) $403.19
- MOUNJARO (Drug) $381.87
- TRELEGY ELLIPTA (Drug) $336.25
- Vascepa (Drug) $332.32
- CHANTIX (Drug) $288.23
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $262.89
- Synthroid (Drug) $220.29
- Aimovig (Biological) $216.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goshen
Dr. Michelle Shelly, Md, MD
Family Medicine — Payments: $10,377
Dr. Laura Munkel, M.d, M.D
Family Medicine — Payments: $6,171
Lenora Hirschler, M.d, M.D
Family Medicine — Payments: $4,662
Timothy Nush, Md, MD
Family Medicine — Payments: $4,597
Dr. Thomas Pechin, M.d, M.D
Family Medicine — Payments: $3,866
John Carey, M.d, M.D
Family Medicine — Payments: $3,321